Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson's disease, STEM-PD. (2023)

First Author: Kirkeby A
Attributed to:  The Pluripotent Stem Cells and Engineered Cell (PSEC) Hub funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.stem.2023.08.014

PubMed Identifier: 37802036

Publication URI: http://europepmc.org/abstract/MED/37802036

Type: Journal Article/Review

Volume: 30

Parent Publication: Cell stem cell

Issue: 10

ISSN: 1875-9777